SCM
ELOX

Silverarc Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Silverarc Capital Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-54,075
Closed -$260K – 96
2023
Q3 		$260K Hold
54,075
– – 0.08% 74
2023
Q2 		$210K Hold
54,075
– – 0.07% 76
2023
Q1 		$136K Buy
54,075
+27,199
+101% +$98.4K 0.06% 70
2022
Q4 		$48.9K Sell
26,876
-586
-2% -$2.83K 0.01% 88
2022
Q3 		$187K Buy
27,462
+1,425
+5% +$17.1K 0.06% 74
2022
Q2 		$281K Sell
26,037
-22,737
-47% -$314K 0.09% 64
2022
Q1 		$1.09K Buy
48,774
+522
+1% +$10.3K 0.45% 51
2021
Q4 		$1.36M Buy
48,252
+16,756
+53% +$730K 0.55% 49
2021
Q3 		$2.05M Sell
31,496
-15,692
-33% -$968K 1.16% 28
2021
Q2 		$3.76K Buy
+47,188
New +$3.94M 1.68% 18

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Silverarc Capital Management's ELOX Position: Q4 2023 in Review

Silverarc Capital Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2023, closing a stake of 54,075 shares — an estimated $260K sold.

Silverarc Capital Management first reported a position in ELOX in Q2 2021 and held it in 10 quarters. The position peaked at $2.05M in Q3 2021. 4 funds tracked by Wall St. Rank hold ELOX as of Q4 2023.

  • Silverarc Capital Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Silverarc Capital Management sold 54,075 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $260K.
  • Silverarc Capital Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Silverarc Capital Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $2.05M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Silverarc Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.